Navigation Links
RANK protein promotes the initiation, progression and metastasis of human breast cancer
Date:4/24/2012

ng pathway may be associated with an increased initiation, progression and metastasis of breast cancer."

Clinic applications

The next step, according to researcher Eva Gonzalez-Suarez, would be "first, confirm these studies with a larger number of samples and secondly explore the therapeutic possibilities."

As explained Gonzalez-Suarez, "there is a theory which says that chemotherapy treatments kill tumour cells but do not affect cancer stem cells, which could reinitiate the tumour after treatment. If indeed this pathway has the ability to restart the tumours and metastatic capacity increase, a combination of RANK inhibitor with chemotherapy may have important therapeutic effects. "

Currently, there is a pharmacological inhibitor of RANK signalling pathway used in clinics, in the treatment of osteoporosis and bone metastases.


'/>"/>
Contact: Jordi Morat
comunicacio@idibell.cat
IDIBELL-Bellvitge Biomedical Research Institute
Source:Eurekalert

Page: 1 2

Related medicine news :

1. New and Delicious, Almond Butter Filled, Cookie Bites With 35.7% Protein to Help Manage Weight and Build Muscle
2. Research highlights role of protein pair in obesity regulation
3. Urine protein test might help diagnose kidney damage from lupus, UT Southwestern researchers find
4. Smithfield, United Food and Commercial Workers Union, and Food Networks Paula Deen to Deliver 150,000 Servings of Protein to San Francisco Food Bank
5. Protein Sciences Corporation Announces Profitable and Cash Flow Positive Results for 2009 and Management Realignment
6. Protein Appears Key to Intestinal Balance
7. SIBLING proteins may predict oral cancer
8. Damaged protein identified as early diagnostic biomarker for Alzheimers disease in healthy adults
9. Cells of aggressive leukemia hijack normal protein to grow
10. Omega Protein Comments on California Lawsuit Alleging Fish Oil Contaminants
11. Proteins May Predict Spread of Colon Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2015)... ... August 29, 2015 , ... "I have been ... Place, N.Y. "I specialize in manual therapy, and my invention will provide headache ... used for additional muscle dysfunction throughout the body." , They developed THE RELIEVER ...
(Date:8/29/2015)... York, NY (PRWEB) , ... August 29, 2015 , ... ... unofficial end of summer (which astronomically, officially ends on September 22nd this year). For ... summer-induced cyber security hangovers linger on which could prove far more costly than a ...
(Date:8/29/2015)... ... August 29, 2015 , ... Vascular Health Sciences ... sell Arterosil and Arterosil HP, and that all claims and counterclaims have been ... Sciences, LLC (VHS) in the United States District Court for the Southern District ...
(Date:8/28/2015)... ... August 28, 2015 , ... The Kentucky State Department ... qualified for the position they are applying for, they are unable to pass the ... are considering altering drug testing policies in order to be able to hire long-term, ...
(Date:8/28/2015)... ... ... As reported by Medical Daily on August 22 , Cellfina, a non-invasive ... two years, the longest of any cellulite reduction system currently on the market. ... solution for their cellulite, according to Dr. Robert Weiss, director of the premier MD ...
Breaking Medicine News(10 mins):Health News:Inventors and InventHelp Clients Develops Tension Reliever (LGI-1951) 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 3Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 4Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 2Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 3Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 4Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 3
... work Scientists now been able to map the most common ... face of future medicine. ,The study called 'HapMap' study ... genetic differences between 269 individuals that originate from different ... Western Europe. The study involved more than 200 scientists ...
... tea is produced from the leaves of the evergreen ... green tea are polyphenolic compounds, known as catechins. Catechins ... dry // ht, including (-)-epigallocatechin gallate (EGCG), (-)-epigallocatechin ... accounts for approximately 50% of the total amounts of ...
... which can be used to reveal the strength of ... assessing// the likelihood of fracturing a particular bone, an ... Research, says. ,Scientists have developed a laser imaging ... bone density thereby predicting future risk of fracturing that ...
... A bacterium strain known as Helicobacter pylori may raise ... study.// ,Two-thirds of the world population carries H. ... for 25 percent of all childhood cancers worldwide. Acute ... childhood leukaemia. ,Clusters of ALL often occur in ...
... The discovery by a young boy of 22 dead geese at ... may have already found its way into the country, though officials ... the town of Neuwied wore biological protection suits to scoop up ... them in metal boxes to the laboratory in nearby Koblenz run ...
... contamination in herbal/ayurvedic medicines, testing of levels of such ... Indian Government has already issued a notification to test ... meant for products meant for export. It is likely ... as well. ,The Department of Ayurveda, Yoga ...
Cached Medicine News:Health News:Catechins in green tea show antiviral effect on influenza virus 2Health News:Birds Flu Scare Reaches Germany 2
(Date:8/28/2015)... N.C. , Aug. 28, 2015  Delays ... research projects can slow down the decision-making process, ... is, therefore, absolutely critical for biopharmaceutical companies to ... research approval process for quicker and more meaningful ... by Best Practices, LLC, nearly three-quarters of benchmarked ...
(Date:8/28/2015)... , August 28, 2015 ... Market by Tumor (Breast, Lung, Prostate) Type (Protein & ... (Diagnostic, Drug Discovery, Prognostic) & Geography - Global Forecast ... is expected to reach around 17,689.0 Million USD by ... period of 2015 to 2020. Browse ...
(Date:8/28/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/686gwf/investigation ... Report on China,s Bevacizumab Market ,2010-2019" report to ... trade name of Avastin, bevacizumab injection is the first ... was approved by CFDA to treat metastatic colorectal cancer. ... all come from Roche and its subsidiary Genectech. ...
Breaking Medicine Technology:Expediting the Pharmaceutical Market Research Process for Faster Insights 2Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 2Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 3Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 4Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 5Investigation Report on China's Bevacizumab Market 2015-2019 2
... June 15 Halt Medical, Inc., today announced that the ... Electrosurgical System for soft tissue ablation using radiofrequency energy.  "This clearance ... investors," said Russ DeLonzor , President and Chief Operating Officer.  ... Radiofrequency ...
... WAYNE, N.J. , June 15 Today, Bayer HealthCare ... Inc., Barr Pharmaceuticals LLC, and Barr Laboratories, Inc. in the Northern ... and patent infringement in connection with Teva,s generic oral contraceptive, Gianvi™. ... leading oral contraceptive YAZ ® .   , ...
Cached Medicine Technology:Halt Medical, Inc. Receives FDA Clearance 2Bayer Sues Teva and Barr for False Advertising and Patent Infringement in Connection with Teva's Generic Oral Contraceptive Gianvi™ 2Bayer Sues Teva and Barr for False Advertising and Patent Infringement in Connection with Teva's Generic Oral Contraceptive Gianvi™ 3Bayer Sues Teva and Barr for False Advertising and Patent Infringement in Connection with Teva's Generic Oral Contraceptive Gianvi™ 4Bayer Sues Teva and Barr for False Advertising and Patent Infringement in Connection with Teva's Generic Oral Contraceptive Gianvi™ 5
... The model 55S Rocking Shaker ... gels and blotted membranes. The very ... adjustable degree of tilt provide a ... washes over gels and blotted membranes ...
... Labsystems Wellmix is a high-quality four-place microplate ... The shaking speed is adjustable from 100 ... speed and a small orbit ensure effective ... time is quick and easy to set ...
... 96 can incubate and shake up to 16 ... at a time. This new system is ... such as Proteinase K digestion. Now you ... preparing your samples with our AutoIncubator 96 and ...
Inquire...
Medicine Products: